U.S., April 11 -- ClinicalTrials.gov registry received information related to the study (NCT06920719) titled 'Bioequivalence Study betweenYHP2406 and YHR2501 in Healthy Subjects' on March 27.
Brief Summary: A randomized, open-label, single-dose, 2-sequence, 2-period, crossover clinical trial to investigate the bioequivalence between YHP2406 and YHR2501 in healthy volunteers
Study Start Date: April 20
Study Type: INTERVENTIONAL
Condition:
Healthy Subject
Intervention:
DRUG: YHP2406
Test drug: YHP2406, Comparator: YHR2501
DRUG: YHR2501
Test drug: YHP2406, Comparator: YHR2501
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Yuhan Corporation
Published by HT Digital Content Services with permission from Health Daily Digest....